Xiaowen specialises in M&A transactions and corporate law structuring of national and international companies. She has particular expertise in the area of corporate transactions and structuring in the healthcare sector, is familiar with the specifics of the highly regulated healthcare sector and has excellent networks there.

 

Of particular note are the approximately 60 M&A transactions for the creation of medical care centre groups as well as nine clinic transactions which underline her successful track record for ongoing advice to various corporate groups. On the product side, Xiaowen is also an experienced legal adviser with medtech, biotech and pharmaceutical transactions, including digital health investments. As a native Chinese speaker and member of the China Group, Xiaowen also advises Chinese companies and investors on outbound activities in Germany and Europe.

显示完整简历 隐藏完整简历

最新新闻和观点

公司/并购与资本市场

Advising workflow platform PassFort on its exit to Moody's Corporation

2021年12月7日

作者 Angus Miln 以及 Ian Moore

点击此处了解更多
公司/并购与资本市场

Advising AI-driven digital platform FYLD on its Series A funding round

2021年12月6日

作者 Siobhán Langwade 以及 Rebecca Le Flufy

点击此处了解更多
技术、媒体与通信 (TMC)

Life sciences and healthcare in 2022 – legislators at work

2021年12月3日
Briefing

作者 Alison Dennis 以及 Justyna Ostrowska

点击此处了解更多
公司/并购与资本市场

Taylor Wessing advises ]init[ AG on strengthening its shareholder base with Gilde Buy Out Partners

2021年12月3日

作者

点击此处了解更多

与我会面: